Equities

Market movers

Constituents of the FTSE 350 with the highest percent gain over one day.
ListingLastChangeVolume
Man Group PLCEMG:LSE199.90
GBX
+12.00
+6.39%
4.73m
Pearson PLCPSON:LSE1,119.50
GBX
+25.50
+2.33%
3.18m
Haleon PLCHLN:LSE351.80
GBX
+6.70
+1.94%
20.88m
Wizz Air Holdings PLCWIZZ:LSE1,168.00
GBX
+22.00
+1.92%
724.37k
Reckitt Benckiser Group PLCRKT:LSE5,910.00
GBX
+106.00
+1.83%
1.88m
Coca Cola HBC AGCCH:LSE3,556.00
GBX
+62.00
+1.77%
1.04m
Domino's Pizza Group PLCDOM:LSE190.00
GBX
+3.30
+1.77%
1.97m
Smiths Group PLCSMIN:LSE2,406.00
GBX
+40.00
+1.69%
955.99k
Unilever PLCULVR:LSE4,665.00
GBX
+75.00
+1.63%
2.80m
Tate & Lyle PLCTATE:LSE382.60
GBX
+6.00
+1.59%
1.65m
Data delayed at least 15 minutes, as of Oct 17 2025 14:50 BST.

Mergers and acquisitions

Mergers and acquisitions across all companies with an updated deal status over the last 90 days

CompaniesDeal statusDeal valueDate
Union Pacific Corp acquired Norfolk Southern CorpAnnounced71.49bn USD29 Jul 2025
Palo Alto Networks Inc acquired Cyberark Software LtdAnnounced25.07bn USD30 Jul 2025
Anglo American PLC acquired Teck Resources LtdAnnounced20.07bn USD08 Sep 2025
Keurig Dr Pepper Inc acquired JDE Peets NVAnnounced18.11bn USD25 Aug 2025
Fifth Third Bancorp acquired Comerica IncAnnounced10.67bn USD06 Oct 2025
95 total results

Institutional Ownership

Company% of available shares heldNet share increase since last reportedValue of change
Cambria Cannabis ETFTOKE:BTQ:USD1.47%+41,992.00%271.27k USD
AB US High Dividend ETFHIDV:PCQ:USD26.36%+16,079.60%25.39m USD
Karyopharm Therapeutics IncKPTI:NSQ18.65%+15,691.33%10.26m USD
Procure Space ETFUFO:NMQ:USD2.81%+6,859.08%2.94m USD
Protara Therapeutics IncTARA:NMQ0.90%+4,100.25%1.34m USD
New York Community Capital Trust VFLG PR U:NYQ0.00%-1.00%-1.10m USD
Nukkleus IncNUKK:NMQ0.00%-1.00%-210.00 USD
Jpmorgan Betabuilders U.S. Treasury Bond 1-3 Year ETFBBSB:BTQ:USD0.00%-1.00%-264.39k USD
Onfolio Holdings IncONFO:NAQ0.00%-1.00%-11.49k USD
Amtech Systems IncASYS:NSQ0.00%-1.00%-310.66k USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.